---
figid: PMC8632454__fped-09-681224-g0002
figtitle: Recent and Upcoming Drug Therapies for Pediatric Heart Failure
organisms:
- Homo sapiens
- Rattus norvegicus
pmcid: PMC8632454
filename: fped-09-681224-g0002.jpg
figlink: /pmc/articles/PMC8632454/figure/F2/
number: F2
caption: Cardiomyocyte pathway of action of the newer drugs currently used or proposed
  in heart failure. NP, neprilysin; sGC, soluble guanylate cyclase; cGMP, cyclic guanylate
  monophosphate; SGLT-2, Sodium glucose co-transporter- 2; P, phosphorylation modification;
  ROS, reactive oxygen species; PPAR-α, peroxisome proliferator activated receptor
  alpha; NO, nitric oxide; NFκB, Nuclear factor kappa B transcription factor; cGMP,
  cyclic guanylate monophosphate; PLN, phospholamban; SERCA, sarcoplasmic/endoplasmic
  reticulum Ca2+-ATPase; ATP, Adenosine triphosphate; cAMP, cyclic adenosine monophosphate;
  VEGF, Vascular endothelial growth factor; ET, endothelin receptors; TGF, Transforming
  growth factor. PKG, protein kinase G; TnI, troponin I; TnC, troponin C; TnT, troponin
  T; Tm, Tropomyosin.
papertitle: Recent and Upcoming Drug Therapies for Pediatric Heart Failure.
reftext: Karla L. Loss, et al. Front Pediatr. 2021;9:681224.
year: '2021'
doi: 10.3389/fped.2021.681224
journal_title: Frontiers in Pediatrics
journal_nlm_ta: Front Pediatr
publisher_name: Frontiers Media S.A.
keywords: pediatric heart failure | sacubitril/valsartan | ivabradine | omecamtiv
  mecarbil | heart failure reduced ejection fraction (HFrEF)
automl_pathway: 0.9677439
figid_alias: PMC8632454__F2
figtype: Figure
organisms_ner:
- Homo sapiens
- Rattus norvegicus
redirect_from: /figures/PMC8632454__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8632454__fped-09-681224-g0002.html
  '@type': Dataset
  description: Cardiomyocyte pathway of action of the newer drugs currently used or
    proposed in heart failure. NP, neprilysin; sGC, soluble guanylate cyclase; cGMP,
    cyclic guanylate monophosphate; SGLT-2, Sodium glucose co-transporter- 2; P, phosphorylation
    modification; ROS, reactive oxygen species; PPAR-α, peroxisome proliferator activated
    receptor alpha; NO, nitric oxide; NFκB, Nuclear factor kappa B transcription factor;
    cGMP, cyclic guanylate monophosphate; PLN, phospholamban; SERCA, sarcoplasmic/endoplasmic
    reticulum Ca2+-ATPase; ATP, Adenosine triphosphate; cAMP, cyclic adenosine monophosphate;
    VEGF, Vascular endothelial growth factor; ET, endothelin receptors; TGF, Transforming
    growth factor. PKG, protein kinase G; TnI, troponin I; TnC, troponin C; TnT, troponin
    T; Tm, Tropomyosin.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - GC
  - TGFB1
  - TGFB2
  - TGFB3
  - DDR1
  - MME
  - PLN
  - PRKG1
  - DNAH8
  - CASR
  - CXADR
  - PRKAR1A
  - SPG7
  - NR1I3
  - TRIM13
  - CXADRP1
  - ATP2A1
  - ATP2A2
  - ATP2A3
  - ACTA1
  - ACTA2
  - ACTB
  - ACTC1
  - ACTG1
  - ACTG2
  - TNC
  - TNNC1
  - TRIM67
  - TNNT1
  - C16orf82
  - MYH14
  - MYO6
  - MYO10
  - MYO16
  - MYO19
  - MYH1
  - MYH10
  - MYH11
  - MYH13
  - MYH15
  - MYH16
  - MYH2
  - MYH3
  - MYH4
  - MYH6
  - MYH7
  - MYH7B
  - MYH8
  - MYH9
  - MYO1A
  - MYO1B
  - MYO1C
  - MYO1D
  - MYO1E
  - MYO1F
  - MYO1G
  - MYO1H
  - MYO3A
  - MYO3B
  - MYO5A
  - MYO5B
  - MYO5C
  - MYO7A
  - MYO7B
  - MYO9A
  - MYO9B
  - MYO15A
  - MYO15B
  - MYO18A
  - MYO18B
  - MYL1
  - MYL3
  - MYL4
  - MYL6
  - MYL6B
  - MYL10
  - MYL12A
  - MYL12B
  - MYL2
  - MYL5
  - MYL7
  - MYL9
  - MYL11
  - ATP1A1
  - ATP1A2
  - ATP1A3
  - ATP1A4
  - ATP1B1
  - ATP1B2
  - ATP1B3
  - ATP1B4
  - TBK1
  - SGCB
  - GUCY1A2
  - GUCY1A1
  - GUCY1B1
  - GUCY1B2
  - SLC25A22
  - SLC5A2
  - PPARA
  - PPARD
  - PPARG
  - Vegfa
  - Gc
  - Tgfb1
  - Mme
  - Pln
  - Nr1i3
  - Tnc
  - Tnni3
  - Tnnt3
  - Gucy1b1
  - Gucy1b2
  - Gucy1a1
  - Slc25a22
  - Slc5a2
  - Ppara
---
